Y. Sheng

发表

Clinical Study of Adjuvant Capecitabine Monotherapy in Chinese Elderly Patients (Aged 55–70) with Stage IIa Breast Cancer

Wei Hu, Jun-yi Shi, Y. Sheng, 2010, Oncology Research and Treatment.

Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.

Yi Zhang, Hengyu Li, Jing Li, 2017, Cancer letters.

Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome

Cheng Xu, Y. Sheng, Hongwei Zhang, 2015, BMC Cancer.

Genetic heterogeneity of HER 2 / Neu in breast carcinoma : a meta analysis

Yue Yu, Y. Sheng, Dongwei Su, 2017 .

KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL

Yue Yu, Lisheng Wang, Y. Sheng, 2016, Anti-cancer drugs.

Effects of bariatric surgery on glycemic and lipid metabolism, surgical complication and quality of life in adolescents with obesity: a systematic review and meta-analysis.

Y. Sheng, Zhi-Ping Huang, Yan Guo, 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Modulation of the number and functions of endothelial progenitor cells by interleukin 1&bgr; in the peripheral blood of pigs: Involvement of p38 mitogen-activated protein kinase signaling in vitro

Y. Sheng, Dongwei Su, Guo-en Fang, 2012, The journal of trauma and acute care surgery.

Characterization of mutations in BRCA1/2 and the relationship with clinic-pathological features of breast cancer in a hereditarily high-risk sample of chinese population

Yue Yu, Y. Sheng, Hengyu Li, 2017, Oncology letters.

CACA Guidelines for Holistic Integrative Management of Breast Cancer

Jian Liu, Yuntao Xie, Jin-hai Tang, 2022, Holistic Integrative Oncology.

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Jin-hai Tang, Junjie Li, Keda Yu, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ultrasound-guided Mammotome system in diagnosis and minimally invasive resection of calcification in breast: Ultrasound-guided Mammotome system in diagnosis and minimally invasive resection of calcification in breast

Wei Hu, Jun-yi Shi, Y. Sheng, 2012 .

Breast malignant adenomyoepithelioma:a case report: Breast malignant adenomyoepithelioma:a case report

Jun-yi Shi, Y. Sheng, Dongwei Su, 2010 .

Bowen’s diease of Nipple-areola complex: a case report: Bowen’s diease of Nipple-areola complex: a case report

Wei Hu, Jun-yi Shi, Y. Sheng, 2011 .

Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.

R. Ling, N. Liao, Junbin Liang, 2018, Oncology letters.

Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery.

Y. Sheng, Zhi-Ping Huang, Yan Guo, 2018, European journal of endocrinology.

Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer

Y. Sheng, Yan-mei Wu, Yu Zhang, 2020, Cancer management and research.

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer

R. Ling, N. Liao, Junbin Liang, 2018, International journal of cancer.

Y. Sheng, Dongwei Su, Yan-mei Wu, 2022, Journal of clinical laboratory analysis.

Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis.

Y. Sheng, Guoping Liu, Kainan Wu, 2016, Oncology reports.

Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer

Yue Yu, Y. Sheng, Dongwei Su, 2017, Molecular carcinogenesis.

A novel germline BRCA1 mutation identified in a family with hereditary breast and ovarian cancer syndrome

Y. Sheng, Yan-mei Wu, J. Dou, 2021, Clinical Medicine Insights. Oncology.

The Survival Time of 8376 Male Breast Cancer Patients.

Y. Wang, Y. Sheng, H. Li, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Jin-hai Tang, Z. Shao, D. Pang, 2016, Health and Quality of Life Outcomes.

[Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].

Guangyu Liu, Y. Sheng, Jun Shi, 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer.

Jun-yi Shi, Y. Sheng, J. Bi, 2017, Oncology letters.

Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III–IV in the Chinese High-Risk Gastric Cancer Population

Y. Sheng, Yingling Liu, Kaiguang Zhang, 2021, Frontiers in Medicine.

Local Control of Breast Conservation Therapy versus Mastectomy in Multifocal or Multicentric Breast Cancer: A Systematic Review and Meta-Analysis

Yue Yu, Y. Sheng, Hao Zhang, 2019, Breast Care.

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

T. Han, Y. Sheng, Hengyu Li, 2015, OncoTargets and therapy.

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration

Yue Yu, Heng-Yu Li, Yue Yu, 2016, BMC Cancer.

Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review.

Jun-yi Shi, Y. Sheng, Yan Guo, 2009, European journal of cancer.

Abstract GS1-08: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (cbcsg010): An open-label, randomised, multicentre, phase 3 trial

Jin-hai Tang, Junjie Li, Keda Yu, 2020 .

Effects of bariatric surgery on breast density in adult obese women: systematic review and meta-analysis

Y. Sheng, Wenyan Dong, Xiang Zhao, 2023, Frontiers in Immunology.

Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells

Chen Huang, Y. Sheng, Ling Wang, 2015, Oncotarget.

Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer

Y. Sheng, Dongwei Su, Yan-mei Wu, 2023, Frontiers in Immunology.

Yue Yu, Y. Sheng, Hengyu Li, 2016, BMC Cancer.